Cart
sales@molnova.com
Butylboronicacid
CAS No. 4426-47-5
Butylboronicacid( —— )
Catalog No. M36861 CAS No. 4426-47-5
Butylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 27 | In Stock |
|
| 1G | 36 | In Stock |
|
Biological Information
-
Product NameButylboronicacid
-
NoteResearch use only, not for human use.
-
Brief DescriptionButylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
-
DescriptionButylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4426-47-5
-
Formula Weight101.94
-
Molecular FormulaC4H11BO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCB(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MALONIC ACID, (P-HYD...
MALONIC ACID, (P-HYDROXYBENZYL)- (7CI) is a natural product.
-
Astressin
Astressin is an amino-terminal truncated analog of CRF that retains high affinity binding to the extracellular domain of the receptor and is believed to act as a neutral competitive antagonist of receptor activation.
-
Methyl retinoate
Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.
